Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient.
about
Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVenous thromboembolism in Latin America: a review and guide to diagnosis and treatment for primary careImpact of thromboprophylaxis across the US acute care settingA clinical decision support system for venous thromboembolism prophylaxis at a general hospital in a middle-income countryEconomic burden of venous thromboembolism in hospitalized patients.Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
P2860
Cost utility of substituting enoxaparin for unfractionated heparin for prophylaxis of venous thrombosis in the hospitalized medical patient.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cost utility of substituting e ...... hospitalized medical patient.
@ast
Cost utility of substituting e ...... hospitalized medical patient.
@en
type
label
Cost utility of substituting e ...... hospitalized medical patient.
@ast
Cost utility of substituting e ...... hospitalized medical patient.
@en
prefLabel
Cost utility of substituting e ...... hospitalized medical patient.
@ast
Cost utility of substituting e ...... hospitalized medical patient.
@en
P2093
P921
P356
P1476
Cost utility of substituting e ...... hospitalized medical patient.
@en
P2093
David Diuguid
Kyriakos Papadopoulos
Luci Leykum
P304
P356
10.1002/JHM.97
P577
2006-05-01T00:00:00Z